Researchers at the University of Michigan Comprehensive Cancer Center have discovered a new class of drugs which reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments.
Researchers unravel mystery of how leukemia-causing mutations enable pre-leukemic stem cells to outperform their healthy counterparts
Researchers at the Children's Medical Center Research Institute at UT Southwestern, the University of California at San Francisco and the University of Michigan Comprehensive Cancer Center have discovered how leukemia-causing mutations enable pre-leukemic stem cells to outperform their healthy counterparts.
After 27 years leading the University of Michigan Comprehensive Cancer Center, founding director Max S. Wicha, M.D., has announced that he will step down as director. While serving as director, Wicha has continued to maintain his laboratory research and clinical practice seeing patients with breast cancer. In 2003, he was part of the team that first identified breast cancer stem cells.
For low-risk women, the likelihood that they get tested for the infection that causes cervical cancer (human papillomavirus or HPV) may depend on what clinic they visit, their doctor's status and whether their provider is male or female, a University of Michigan Health System study shows.
Researchers from the University of Michigan Comprehensive Cancer Center have identified a type of mutation that develops after breast cancer patients take anti-estrogen therapies. The mutations explain why patients become resistant to this therapy.
Researchers from the University of Michigan Comprehensive Cancer Center have identified new proteins that control the function of critical immune cell subsets called T-cells, which are responsible for a serious and often deadly side effect of lifesaving bone marrow transplants.
Eric Fearon among 3 U-M faculty members in this year's class.
Adrenal cancer researchers at the University of Michigan Comprehensive Cancer Center are seeing the results of their laboratory studies translate to a clinical trial to test a potential new therapy in patients.
The University of Michigan's Breast Oncology Program to benefit from QVC Presents "FFANY Shoes on Sale"
Net proceeds from 20th annual "FFANY Shoes on Sale" charitable shoe sale to support breast cancer research, education nationwide.
Ann Arbor-area residents have one last opportunity to join the movement to create a world with less cancer and more birthdays by participating in Cancer Prevention Study-3 (CPS-3), a historic study that has the potential to change the face of cancer for future generations.